# ARK Invest Trims Teradyne Stake as Firm Backs Multiply Labs

- URL: https://stocks.freetheai.org/news/ark-invest-trims-teradyne-stake-as-firm-backs-multiply-labs-790a97
- Published: 2026-10-12T11:00:00Z
- Category: company_news; sentiment: mixed; impact: medium
- Symbols: [NASDAQ:TER](https://stocks.freetheai.org/symbols/NASDAQ-TER)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

ARK Invest reduced its holding in Teradyne, Inc. (TER) on Oct. 6, 2026, selling approximately 61,547 shares worth about $26.5 million. The sale was part of portfolio reallocations. During the same period, Teradyne participated in a $75 million Series B funding round for Multiply Labs to support the scaling of automated drug manufacturing capabilities.

The transaction by ARK Invest occurred despite Teradyne, Inc. (TER) delivering strong second-quarter 2026 financial results, supported by demand for artificial intelligence test equipment. Meanwhile, the investment in Multiply Labs, made alongside AstraZeneca and other backers, marks an expansion of Teradyne's involvement in advanced production technology.

Investors will watch how demand for AI testing equipment continues to drive core revenue while the company engages in targeted healthcare automation investments. Teradyne, Inc. (TER) shares were up 0.99% to $402.70.

## Key points

- ARK Invest sold approximately 61,547 shares of Teradyne, Inc. (TER) valued at around $26.5 million on Oct. 6, 2026.
- The trimming was driven by portfolio reallocations despite strong second-quarter 2026 financial performance at Teradyne.
- Teradyne joined a $75 million Series B investment round for Multiply Labs alongside AstraZeneca and other backers.
- The funding round will help Multiply Labs scale its drug manufacturing and production capabilities.

## Questions and answers

### Why did ARK Invest reduce its position in Teradyne?

ARK Invest sold roughly 61,547 shares of Teradyne, Inc. (TER) worth about $26.5 million as part of portfolio reallocations, despite Teradyne reporting strong Q2 2026 financial results and solid AI test-equipment demand.

### What is Multiply Labs' funding round?

Multiply Labs raised $75 million in a Series B round, joined by Teradyne, Inc. (TER), AstraZeneca, and other investors, to scale its drug manufacturing capabilities.

### What was Teradyne's recent stock price?

Teradyne, Inc. (TER) was trading at $402.70, up 0.99% for the day.